New Mexico Register / Volume XXX, Issue 10 / May 28, 2019

 

 

NOTICE OF REGULAR BOARD MEETING AND RULE HEARING

 

 

The New Mexico Board of Pharmacy will convene on June 27th & 28th, 2019 at 9:00 a.m. and continue until finished in the Board of Pharmacy Conference Room located at 5500 San Antonio Dr., NE, Albuquerque, NM 87109 for the purpose of conducting a regular board meeting.

 

The agenda is posted 72 hours prior to the scheduled meeting. You may view and download a copy of the agenda through the board’s website: www.rld.state.nm.us/boards/pharmacy.aspx.  All proposed language regarding rule hearings is linked on the Agenda; and posted under to the board’s website under Hearing Notices at least 30 days prior.

 

Persons wishing to comment on proposed language regarding rule hearings may submit information and comment on the proposed rule.  The information or comment may be submitted in an electronic or written format.  Public comment is allowed up to and during the rule hearing. Individuals petitioning the board regarding requests/waivers must submit documentation for presentation; via fax (505) 222-9845, mail or email to the Executive Director, Cheranne McCracken, Cheranne.McCracken@state.nm.us at least five days in advance of the scheduled meeting, if in attendance must also provide 12 copies of that documentation for distribution to board members and staff (Board staff is not required to make copies).

 

The board may go into Executive Session to discuss items pursuant to Section 10-15-1H (1), Section 10-15-1H (2), Section 10-15-1H (3) or Section 10-15-1H (7) of the Open Meeting Act.  Agenda items may be executed at any time during the meeting to accommodate hearings.

 

If you are an individual with a disability who is in need of a reader, amplifier, qualified sign language interpreter, or any other form of auxiliary aid or service to attend or participate in the hearing or meeting, please contact Kristina Benavidez at 505-222-9878 at least one week prior to the meeting or as soon as possible. Public documents, including the agenda and minutes, can be provided in various accessible formats. Please contact Kristina Benavidez, at 505-222-9878 or e-mail kristina.benavidez@state.nm.us if a summary or other type of accessible format is needed.

 

The Board will address:

 

All Board Matters:

 

Rule Hearings:

 

16.19.5 NMAC – INTERNSHIP TRAINING PROGRAM:  Amendment to Section 7; amending prerequisite credit hours for pharmacist intern licensure from 30 semester hours to satisfactory completion of all first semester courses.

 

The purpose of this change is to update the licensure prerequisites for consistency with current college of pharmacy curriculum.  The 30 semester hour requirement applied to the Bachelors of Science of Pharmacy (BSP) degree, which was replaced by the Doctor of Pharmacy (PharmD) program around 2000.  The PharmD program is two years longer than the BSP, and first year PharmD students have completed an extra year of training compared to first year BSP students.  Pharmacist intern licensure after successful completion of the first semester in the PharmD program will allow for more patient care training, with a targeted outcome of better trained pharmacists, to benefit the health and safety of the public.

 

STATUTORY AUTHORITY:  Subsection B of Section 61-11-11 NMSA 1978.

 

16.19.12 NMAC- FEES:  Amendment to Sections 1, 2, 3, 9, 13, 16, 17, 19 and 20: administrative updates, board contact information; statutory authority; decrease pharmacy technician registration fee; waiver of registration fees for military service members and spouses for change of duty location to NM; increase fee for nonresident pharmacies that dispense compounded sterile preparations into NM; clarification of fee application and intervals.

 

The purpose of this change is to update, and clarify each amended section.  The waiver of fees for military service member and spouses for change of duty location is to minimize barriers to licensure and employment, while the increased fee for nonresident sterile compounding pharmacies is consistent with the additional work necessary to screen applications for licensure and renewal.  The differentiation will further support compliance with operational standards, as in the case of a licensed nonresident pharmacy that intends to begin shipping sterile compounded preparations into NM.

 

STATUTORY AUTHORITY:  Sections 30-31-11, 30-31B-6, 61-11-12, 61-11-13, and 61-11-14 NMSA 1978

 

Disciplinary Hearings: note – the information below is tentative.  Final hearing date and time for each case will be included in the agenda posted to the board’s website at least 72 hours before the meeting.

6/27/2019 @ 1:30 p.m.  Andrew Ngo, PT 9564, IN 3543, pharmacist license examination applicant, Case

2017-044B

6/28/2019 @ 9:30 a.m.  Kelly Kemper, RP 5290, Case 2018-061

6/28/2019 @ 1:00 p.m.  Joel Villarreal, RP 6498, Case 2017-050

*Additional hearing, if scheduled, will be included in the agenda

 

Executive Director’s Report:

 

Published in the NM Register May 28, 2019